NEW YORK (GenomeWeb) – Drug discovery firm Selvita today said that it has formed a subsidiary called Ardigen to take over its bioinformatics business.

Ardigen's big data integration and analysis services business and custom application development operations will expand Selvita's bioinformatics services, Selvita said. Ardigen will form a new business unit focused on biological and clinical data analysis in genomics, transcriptomics, proteomics, metabolomics, and immunomics, and will also create a business unit around personalized medicine products and services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.